(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

WELLINGO

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

WELLINGO

ST13

US500000079265691

Classe

9, 10, 44

Pedido

79265691

Registro

6224326

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

46

Atualização mais recente

23/12/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 10, 44

Data de depósito

18/12/2018

Data de registro

22/12/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

22/12/2020

Última transação

23/12/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

34

Localização do titular

FR

Examinador

BLACK,MILDRED ELIZABETH

Unidade examinadora

O30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

BIOFARMA

Representantes

Maury M. Tepper, III Tepper & Eyster, PLLC

Classificação técnica

Classes Nice

Classe 9Classe 10Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Scientificweighingmeasuringsignalingcheckingsupervisionlife-saving and teaching apparatus and instrumentscomputersmicroscopes for scientific or research purposes in the fields of neuropsychiatric diseasesimmune-inflammatory diseasescardiovascular diseasesdiabetes and cancers; apparatus and instruments for conductingswitchingtransformingaccumulatingregulating or controlling electricity; apparatus for recordingtransmission or reproduction of sound or images;apparatus for use with medical patient monitoring equipmentfor receivingprocessingtransmitting and displaying datafor controlling and managing patient medical informationfor providing information on health and wellness and to enable healthcare professionals to receive and track patient data relating to vital signssymptoms and medication compliance; computers; software recorded on magnetic media or downloaded from a remote computer network for controlling and managing patient medical informationexcluding optical prescriptions or other medical information related to the eye; personal digital assistant; transmitters of electronic signals; video cameras; activity sensorswearable activity trackers; downloadable applications for mobile devices to enable users to track their symptomsphysical activity and vital signs unrelated to the eye and to record and share such information with healthcare professionals; in-ear headphones; virtual reality helmets; all of the foregoing excluding goods for ophthalmologyoptometryvision correctionhealth and treatment of the eye

Classe 10

Medical analysis apparatusinstruments and equipment for the prevention and treatment of heart diseases; artificial teethorgans and limbs; orthopedic supports; suture material; medical compression stockingstights and socks; medical stockingstights and socks for varicose veins; medical apparatusinstruments and equipment for introducing pharmaceutical preparations into the human body for the prolongedcontrolled or immediate release of active substances; perfusion devices and syringes for medical use; medical measuring instrumentsmedical instruments able to directly transmit data to a database in the field of fever measuring instrumentsheart rate monitors; endoscopic equipment in the nature of endoscopic video capsules for medical purposes; medical apparatus for measuring biochemical changes in blood; inhalers for medical use; blood pressure monitors; all of the foregoing excluding goods for ophthalmologyoptometryvision correctionhealth and treatment of the eye

Classe 44

Medical services; veterinary services; hygienic and beauty care for human beings or animals; advisory services relating to health; telemedicine services; medical diagnosis services; home health care services; individualized medical prescription refill reminder services; online medical prescription servicesinteractive medical monitoring and alert service for reminding clients of medicinal dosageallergy sensitivityprescription refills for medical treatment purposes; consultancy in relation to medical treatment in the home; advice relating to self-medicationproviding medical advice in the field of individuals managing their own medication regimen; provision of medical information to patients; remote medical examination services; medical monitoring of patients and remote monitoring of medical data for medical assistance services; all of the foregoing excluding services in the fields of ophthalmologyoptometryvision correctionhealth and treatment of the eye

Publicações

Histórico de despachos e eventos da marca no USPTO.

46 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

22/12/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

18/04/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

25/03/2021

FIMP

FINAL DISPOSITION PROCESSED

25/03/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

22/03/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

22/12/2020

CHPB

POST PUBLICATION AMENDMENT - ENTERED

18/11/2020

APET

ASSIGNED TO PETITION STAFF

18/11/2020

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

01/11/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

02/10/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

01/10/2020

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

20/07/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

23/06/2020

PUBO

PUBLISHED FOR OPPOSITION

23/06/2020

GPNX

NOTIFICATION PROCESSED BY IB

19/06/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/06/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/06/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/06/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

18/05/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

24/04/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/04/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/04/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/04/2020

GNRT

NON-FINAL ACTION E-MAILED

04/04/2020

CNRT

NON-FINAL ACTION WRITTEN

04/04/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/03/2020

ALIE

ASSIGNED TO LIE

13/03/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/03/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

19/02/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

19/02/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

19/02/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

19/02/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

19/02/2020

RFNT

REFUSAL PROCESSED BY IB

19/10/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/10/2019

RFRR

REFUSAL PROCESSED BY MPU

30/09/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

17/09/2019

CNRT

NON-FINAL ACTION WRITTEN

16/09/2019

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

16/09/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/09/2019

CNRT

NON-FINAL ACTION WRITTEN

05/09/2019

MAFR

APPLICATION FILING RECEIPT MAILED

03/09/2019

DOCK

ASSIGNED TO EXAMINER

30/08/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

30/08/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

22/08/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace WELLINGO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.